Plum SEC
  • Korean Stock
  • Company Information
  • Customer Service

Korean Stock

전체 공시
OWNR
Jin Yang Pharmaceutical
★
Filing of Large Shareholding Report (No Change)
 05/18/2026, 03:56 PM
OWNR
Jin Yang Pharmaceutical
★
No change in specific securities ownership by executives and major shareholders
 05/18/2026, 03:14 PM
PERI
Jin Yang Pharmaceutical
★
Jinyang Pharmaceutical Q1 2026: Revenue 32.4B, Operating Profit 3.4B; High Debt and CB Dilution Risk
 05/15/2026, 11:34 AM
  • «
  • 1
  • »
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.15